Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 May;6(10):186.
doi: 10.21037/atm.2018.03.06.

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

Conor F Murphy  1 , Carel W le Roux  1   2
Affiliations
Editorial

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

Conor F Murphy et al. Ann Transl Med. 2018 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: CW le Roux serves on advisory boards for NovoNordisk, Johnson & Johnson, GI Dynamics, Fractyl and Herbalife. CF Murphy has no conflicts of interest to declare.

Comment on

References

    1. le Roux CW, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet 2017;389:1399-409. 10.1016/S0140-6736(17)30069-7 - DOI - PubMed
    1. Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med 2015;373:11-22. 10.1056/NEJMoa1411892 - DOI - PubMed
    1. Potts JE, Gray LJ, Brady EM, et al. The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis. PLoS One 2015;10:e0126769. 10.1371/journal.pone.0126769 - DOI - PMC - PubMed
    1. Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2016;375:311-22. 10.1056/NEJMoa1603827 - DOI - PMC - PubMed
    1. Pyke C, Heller RS, Kirk RK, et al. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology 2014;155:1280-90. 10.1210/en.2013-1934 - DOI - PubMed